Fortis Healthcare launches Fortis Institute of Genomic Medicine
The institute will bring together a team of medical experts, including molecular hematology, oncology, neurology, paediatrics, pathology, and genomic scientists along with bioinformaticians and AI engineers
Fortis Healthcare launched ‘Fortis Institute of Genomic Medicine, ’ to advance patient care by utilising the power of genomic science across India. Backed by Fortis’ clinical ecosystem and Agilus Diagnostics’ national footprint, the institute will bring together a multi-disciplinary team of medical experts, including molecular hematology, oncology, neurology, paediatrics, pathology, and genomic scientists along with bioinformaticians and AI (artificial intelligence) engineers.
Genomics is transforming the future of modern medicine and treatment modalities across specialties – oncology, cardiology, and neurology. Onco-genomics will help clinicians decode the genetic drivers of cancer, enabling targeted therapies that are more effective and less toxic than traditional one-size-fits-all treatments. Cardio-genomics will empower the early detection of inherited cardiac conditions, crucial for families with a history of sudden cardiac arrest, unexplained heart failure, or congenital heart disease. Meanwhile, Neuro-genomics will offer new hope for patients with complex neurological disorders, using gene-based insights to improve diagnosis and personalise interventions for conditions like epilepsy, Parkinson’s and rare neurodevelopmental syndromes.
Shortly, Fortis also aims to launch a genomics-informed health registry, along with an AI-powered genomic reporting platform designed specifically for Indian clinicians as per international recommendations by ACMG (American College of Medical Genetics and Genomics), AMP (Association for Molecular Pathology), and ASCO (American Society of Clinical Oncology) – which will be compliant, clinically relevant, and intuitively designed for seamless integration into medical practice.
Key medical experts from FMRI present at the launch event included Dr Rahul Bhargava, Principal Director and Chief, Bone Marrow Transplant; Dr Vinayak Agarwal, Senior Director & Head, Non-Invasive Cardiology; Dr Praveen Gupta, Principal Director & Chief of Neurology; Dr Nitesh Rohatgi, Senior Director, Medical Oncology, FMRI, Gurugram; Dr Ankur Bahl, Senior Director, Medical Oncology; Dr Shrinidhi Nathany, Consultant, Molecular Haematology and Oncology; Yash Rawat, Facility Director; and Dr Ritu Garg, Chief Marketing and Innovation Officer, Fortis Healthcare
- Advertisement -